Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study

被引:81
|
作者
Ho, Siew Ching [1 ]
Jacob, Sabrina Anne [2 ]
Tangiisuran, Balamurugan [1 ,3 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[2] Monash Univ Malaysia, Sch Pharm, Selangor, Malaysia
[3] Univ Sains Malaysia, Natl Poison Ctr, WHO Collaborating Ctr Drug Informat, George Town, Malaysia
来源
PLOS ONE | 2017年 / 12卷 / 06期
关键词
PRIMARY-CARE; AFRICAN-AMERICANS; PATIENTS BELIEFS; PATIENT TRUST; MEDICATION; ATTITUDES; THERAPY; HEALTH; HARMFULNESS; PREVALENCE;
D O I
10.1371/journal.pone.0179290
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background One of the major challenges in treating major depressive disorder (MDD) is patients' non-adherence to medication. This study aimed to explore the barriers and facilitators of patients' adherence to antidepressants among outpatients with MDD. Methods Semi-structured and individual in-depth interviews were conducted among patients with MDD who were taking antidepressants, in the psychiatric clinic of a government-run hospital in Malaysia. Participants were purposively sampled from different genders and ethnicities. Interviews were conducted using a validated topic guide, and responses were audio-recorded, transcribed verbatim, checked, and analyzed using the grounded theory approach. Results A total of 30 patients were interviewed. Forty different themes and sub-themes were identified which were conceptually divided into two distinct categories related to barriers and facilitators to adherence. The barriers were: patient-specific, medication-specific, healthcare provision and system, social-cultural, and logistics. The facilitators were: having insight, perceived health benefits, regular activities, patient-provider relationship, reminders, and social support networks. Conclusions Patient-specific barriers and medication side effects were the major challenges for adhering to treatment. Perceived health benefits and having insight on the need for treatment were the most frequently cited facilitators. Targeted interventions should be developed to address the key barriers, and promote measures to facilitate adherence in this group of patients.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Adherence Barriers, Facilitators And Resilience In Patients With Severe Asthma: A Qualitative Study
    Foster, J. M.
    McDonald, V. M.
    Guo, M.
    Reddel, H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [32] Efficacy of antidepressants in the treatment of major depressive disorder: a naturalistic study
    Balague Ano, A.
    Olles, M. V.
    Gento, P.
    Turnes, E.
    Calvo, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S332 - S333
  • [33] Quality of life among Iranian major depressive disorder patients: a qualitative study
    Rezaiye, Milad
    Radfar, Moloud
    MaslakPak, Masumeh Hemmati
    [J]. MIDDLE EAST CURRENT PSYCHIATRY-MECPSYCH, 2023, 30 (01):
  • [34] Quality of life among Iranian major depressive disorder patients: a qualitative study
    Milad Rezaiye
    Moloud Radfar
    Masumeh Hemmati MaslakPak
    [J]. Middle East Current Psychiatry, 30
  • [35] Barriers to and Facilitators of Adherence to Antiretroviral Therapy Among People Living With HIV in Lao PDR: A Qualitative Study
    Portelli, Monique S.
    Tenni, Brigitte
    Kounnavong, Sengchanh
    Chanthivilay, Phetsavanh
    [J]. ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2015, 27 (02) : NP778 - NP788
  • [36] Barriers and Facilitators to Seek Help for Substance Use Disorder among Dutch Physicians: A Qualitative Study
    Geuijen, Pauline M.
    Pars, Esther
    Kuppens, Joanneke M.
    Schene, Aart H.
    de Haan, Hein A.
    de Jong, Cornelis A. J.
    Atsma, Femke
    Schellekens, Arnt F. A.
    [J]. EUROPEAN ADDICTION RESEARCH, 2022, 28 (01) : 23 - 32
  • [37] Separation anxiety disorder among outpatients with major depressive disorder: Prevalence and clinical correlates
    Elbay, Rumeysa Yeni
    Gormez, Aynur
    Kilic, Alperen
    Avci, Selma Hilal
    [J]. COMPREHENSIVE PSYCHIATRY, 2021, 105
  • [38] Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder
    Vega, Charles
    Becker, Russell V.
    Mucha, Lisa
    Lorenz, Betty H.
    Eaddy, Michael T.
    Ogbonnaya, Augustina O.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (10) : 1879 - 1889
  • [39] Depression facilitators from the perspective of Iranian patients with major depressive disorder: a qualitative research
    Rezaiye, Milad
    Radfar, Moloud
    MaslakPak, Masumeh Hemmati
    [J]. EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01):
  • [40] Major depressive disorder, antidepressants, and sexual dysfunction
    Clayton, Anita H.
    Montejo, Angel L.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 : 33 - 37